Ferriprox (deferiprone))
pCPA File Number:
22202
Negotiation Status:
Under consideration for negotiation
Indication(s):
For the treatment of patients with transfusional iron overload due to sickle cell disease or other anemias
Sponsor/Manufacturer:
Chiesi Canada Corporation
CADTH Project Number:
SR0741
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable